Evaluation of DOAC Dosing Among Various Renal Equations in Patients With Kidney Impairment and Elderly in Thailand

Documenti analoghi

• Population Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy: Influence of Adsorptive Membranes
  di: Chidtawan Hirunsomboon, et al.
  Pubblicazione: (2026)
• Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review
  di: Thanakorn Surarak, et al.
  Pubblicazione: (2024)
• Mortality factors and antibiotic options in carbapenem‐resistant Enterobacterales bloodstream infections: Insights from a high‐prevalence setting with co‐occurring NDM‐1 and OXA‐48
  di: Palat Karnmueng, et al.
  Pubblicazione: (2024)
• Pharmacokinetics of Bocidelpar, ASP0367, in Renal and Hepatic Impairment: Results From Two Phase 1 Studies
  di: Megumi Iwai, et al.
  Pubblicazione: (2025)
• Causal Effects of Renin–Angiotensin–Aldosterone System Inhibition on Renal Function in Patients With Chronic Kidney Disease: A Quasi‐Experimental Study
  di: Tae Ryom Oh, et al.
  Pubblicazione: (2026)